155 related articles for article (PubMed ID: 29730194)
1. Natriuretic peptides in acute coronary syndromes: A new role to predict recurrent ischemic event-related mortality?
Bistola V; Polyzogopoulou E; Parissis J
Hellenic J Cardiol; 2018; 59(2):119-121. PubMed ID: 29730194
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides in acute chest pain and acute coronary syndrome: from pathophysiology to clinical and prognostic applications.
Aspromonte N; Di Fusco SA; Latini R; Cruz DN; Masson S; Tubaro M; Palazzuoli A
Coron Artery Dis; 2013 Jan; 24(1):33-9. PubMed ID: 23164752
[TBL] [Abstract][Full Text] [Related]
3. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
Maeder M; Fehr T; Rickli H; Ammann P
Chest; 2006 May; 129(5):1349-66. PubMed ID: 16685029
[TBL] [Abstract][Full Text] [Related]
4. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
[TBL] [Abstract][Full Text] [Related]
5. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
6. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications.
Farmakis D; Filippatos G; Tubaro M; Peacock WF; Disomma S; Mueller C; Kremastinos DT; Maisel AS
Congest Heart Fail; 2008; 14(4 Suppl 1):25-9. PubMed ID: 18772630
[TBL] [Abstract][Full Text] [Related]
8. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
9. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study.
Perna ER; Aspromonte N; Cimbaro Canella JP; Di Tano G; Macin SM; Feola M; Coronel ML; Milani L; Parras JI; Milli M; García EH; Valle R
J Card Fail; 2012 Nov; 18(11):822-30. PubMed ID: 23141854
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK; Januzzi JL
Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
13. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
14. [Impact of natriuretic peptides in current clinical practice].
Ganovská E; Špinar J; Pařenica J
Vnitr Lek; 2014; 60(5-6):474-83. PubMed ID: 24974752
[TBL] [Abstract][Full Text] [Related]
15. Novel biomarkers in heart failure with preserved ejection fraction.
Shah KS; Maisel AS
Heart Fail Clin; 2014 Jul; 10(3):471-9. PubMed ID: 24975910
[TBL] [Abstract][Full Text] [Related]
16. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in acute coronary syndrome and percutaneous coronary intervention.
Searle J; Danne O; Müller C; Mockel M
Minerva Cardioangiol; 2011 Jun; 59(3):203-23. PubMed ID: 21516070
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic Peptides in Clinical Practice.
Çavuşoğlu Y; Alper AT; Altay H; Çelik A; Demirkan B; Güvenç TS; Küçükoğlu MS; Nalbantgil S; Özdemir M; Özin B; Sayın T; Yıldırımtürk Ö; Yılmaz MB; Zorkun C
Anatol J Cardiol; 2019 Mar; 21(Suppl 1):1-40. PubMed ID: 30860204
[TBL] [Abstract][Full Text] [Related]
19. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes.
Jansson AM; Hartford M; Omland T; Karlsson T; Lindmarker P; Herlitz J; Ueland T; Aukrust P; Caidahl K
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3041-9. PubMed ID: 23023373
[TBL] [Abstract][Full Text] [Related]
20. Circulating natriuretic peptide levels in acute heart failure.
Maisel A
Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
